Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Window of Opportunity Study of IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma

NCT03795610 is registered in ClinicalTrials.gov with Assuntina G. Sacco, MD as lead sponsor.

NCT NCT03795610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03795610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Window of Opportunity Study of IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
Lead sponsor
Assuntina G. Sacco, MD
Phase
Phase 2
Overall status
Completed
Start date
March 6, 2020
Completion date
August 24, 2023
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, head and neck cancer stage iii, head and neck cancer stage iv, head and neck carcinoma, head and neck squamous cell carcinoma, hpv-related carcinoma, hpv-related malignancy, hpv-related squamous cell carcinoma